How many drugs were approved in 2022?

Drug Landscape tracks 70 drug approvals with a first_approval_date in 2022 (FDA, EMA, MHRA, PMDA combined). The full list is on this page, each linked to its primary regulatory source.

Which patents expired in 2022?

2 patents on currently-marketed drugs reached their listed expiry date in 2022. Each entry links back to the drug profile with full Orange Book data.

What Phase 3 readouts happened in 2022?

No Phase 3 trials have completion dates in 2022.

Where does this data come from?

Approvals from FDA Drugs@FDA, EMA EPAR, MHRA, and PMDA. Patent data from FDA Orange Book + USPTO PAIR. Trial data from ClinicalTrials.gov. Updates daily.

2022 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2022: 70 approvals, 2 patent expiries, 0 Phase 3 milestones.

2020 2021 2022 2023 2024

FDA / EMA / MHRA approvals (70)

2023 — Etrasimod · Pfizer · Immunology
2023 — FECAL MICROBIOTA SPORES, LIVE
2023 — ZAVEGEPANT
2023 — ROZANOLIXIZUMAB
2023 — Litfulo · Pfizer · Oncology
2023 — Paxlovid (Copackaged) · Pfizer · Infectious Disease
2023 — Ycanth · Verrica Pharms · Infectious Disease
2023 — GEFAPIXANT
2023 — Zynyz · Incyte Corp · Oncology
2023 — Columvi · Roche · Oncology
2023 — RITLECITINIB
2023 — ELRANATAMAB
2023 — Casgevy
2023 — BACILLUS ANTHRACIS PROTECTIVE ANTIGEN, ADSORBED
2023 — DURLOBACTAM SODIUM
2023 — PEGZILARGINASE
2023 — Izervay · Astellas Pharma · Immunology
2023 — Ga-68-DOTATOC · Uihc Pet Imaging · Oncology
2023 — Lyfnua · Msd K.K. · Pain
2023 — Skyclarys · Biogen Us · Other
2023 — Paxlovid (Copackaged) · Pfizer · Infectious Disease
2023 — Elfabrio · Chiesi Farmaceutici S.P.A · Metabolic
2023 — Vanflyta · Daiichi Sankyo Inc · Oncology
2023 — Inpefa · Lexicon Pharms Inc · Metabolic
2023 — Agamree · Catalyst Pharms · Immunology
2023 — Zavzpret · Pfizer · Neuroscience
2023 — PROTHROMBIN · Metabolic
2023 — Epkinly · Genmab Us, Inc. · Oncology
2023 — Beyfortus · AstraZeneca · Infectious Disease
2023 — Zavzpret · Pfizer · Neuroscience
2023 — Ngenla · Pfizer Ireland Pharmaceuticals · Metabolic
2023 — Paxlovid (Copackaged) · Pfizer · Immunology
2023 — Augtyro · Bristol · Oncology
2023 — Paxlovid (Copackaged) · Pfizer · Immunology
2023 — Ioflupane I 123 · Ge Hlthcare Inc · Neuroscience
2023 — Xacduro (Copackaged) · Entasis Therap · Infectious Disease
2023 — Elrexfio · Pfizer · Oncology
2023 — SPARSENTAN
2023 — GLOFITAMAB
2023 — RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F
2023 — Taurolin · Immunology
2023 — Jesduvroq · GSK · Hematology
2023 — Eslicarbazepine Acetate · Sumitomo Pharma Am · Neuroscience
2023 — Miebo · Bausch Health · Ophthalmology
2023 — Pombiliti · Amicus Therapeutics Europe Limited · Metabolic
2023 — Posluma · Blue Earth · Oncology
2023 — Qalsody · Biogen Ma · Rare Disease
2023 — Veozah · Astellas Pharma · Neuroscience
2023 — Zurzuvae · Biogen · Neuroscience
2023 — Litfulo · Pfizer · Immunology
2023 — Litfulo · Pfizer · Dermatology
2023 — Veopoz · Regeneron · Immunology
2023 — Sohonos · Ipsen · Bone
2023 — GEPIRONE · Neuroscience
2023 — Brenzavvy · Theracosbio · Metabolic
2023 — Elrexfio · Pfizer · Oncology
2023 — Talvey · Janssen Biotech · Oncology
2023 — AVACINCAPTAD PEGOL SODIUM · Immunology
2023 — Joenja · Pharming · Immunology
2023 — Orserdu · Stemline Therap · Oncology
2023 — Xdemvy · Tarsus · Other
2023 — Ngenla · Pfizer Ireland Pharmaceuticals · Metabolic
2023 — Elrexfio · Pfizer · Oncology
2023 — Daybue · Acadia Pharms Inc · Other
2023 — ELACESTRANT HYDROCHLORIDE
2023 — Omvoh · Eli Lilly Nederland B.V. · Immunology
2023 — ELTROMBOPAG CHOLINE
2023 — VADADUSTAT
2023 — Leqembi · Eisai · Immunology
2023 — Fabhalta · Novartis · Immunology

Patent expiries (2)

Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Fluvastatin, Tacrolimus, Mycophenolat Mofetil · US4888399A · US
Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Quetiapine 600mg · US5229382A · US

Phase 3 readouts (0)

No entries tracked.